Checkweigher for Pharma Packaging Inspection Aids Traceability
The WIPOTEC-OCS TQS-HC-A-TE Checkweigher combines weight control with traceability and anti-counterfeiting capabilities.
WIPOTEC-OCS
WIPOTEC-OCS's compact, three-in-one checkweigher/serialization/tamper-evidence module for pharmaceutical applications has a small footprint machine design. The TQS-HC-A-TE Checkweigher combines precision weight monitoring, using electro-magnetic force restoration technology, with traceability and anti-counterfeiting elements increasingly required on pharmaceutical packaging lines, says the company.
The machine can perform serialization tasks, such as in-line printing of batch or unique product identifiers, print verification, and adding extra sensory data to a product’s unique identifier. It is equipped with tamper-evident labeling systems on both sides, allowing pharma manufacturers to seal the insertion flaps of folding boxes or apply further anti-counterfeiting vignettes from above. Combined, the traceability and tamper-evidence elements provide compliance with all foreseeable worldwide serialization, including the US Drug Supply Chain Security Act and the European Union’s Falsified Medicines Directive.
The ConfigureFast User Interface, the transport system, coding unit, camera, scales, and labeler are all controlled with a single software application. The machine can handle up to 300 products per minute, with an upgrade available that doubles throughput capacity to as many as 600/min at a reduced printing resolution. Its maximum weighing range of 750 g also can be doubled, and options also are available that expand the base unit’s maximum product length (120 mm), height (150 mm) and depth (200 mm).
Source: WIPOTEC-OCS
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Innovative Solutions in Pre-Filled Syringes for Biologics and Ophthalmic Applications
May 5th 2025Don't miss this webinar delving into: - How to streamline the selection of the primary container and delivery device - How to overcome silicone challenges in PFSs - How to enhance the delivery of highly viscous drug formulation
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Container selection for a highly sensitive drug product: a success story
May 5th 2025For new drug products, it is essential that pharmaceutical companies utilize the experience of container suppliers as early as possible. Read this white paper and discover how Stevanato Group can support you from start to finish.
Design testing strategies to develop a drug-device combination product
May 5th 2025Commercializing a drug-device combination product is a complex challenge to handle alone. Learn how Stevanato Group’s Technology Excellence Centers can provide guidance and execution through the various steps of a Validation Master Plan.
